Ligand Pharmaceuticals LGND Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's common stock?
- Ligand Pharmaceuticals (LGND) reported common stock of 60M in Q1 2026.
- How has Ligand Pharmaceuticals's common stock changed year-over-year?
- Ligand Pharmaceuticals's common stock decreased by 0.0% year-over-year, from 60M to 60M.
- What is the long-term trend for Ligand Pharmaceuticals's common stock?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's common stock has grown at a 418.6% compound annual growth rate (CAGR), from 16K to 60M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).